These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18537655)

  • 1. Recent advances in drugs and prodrugs design of chitosan.
    Vinsova J; Vavrikova E
    Curr Pharm Des; 2008; 14(13):1311-26. PubMed ID: 18537655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan derivatives with antimicrobial, antitumour and antioxidant activities--a review.
    Jarmila V; Vavríková E
    Curr Pharm Des; 2011; 17(32):3596-607. PubMed ID: 22074429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel melphalan polymeric prodrug: preparation and property study.
    Li D; Lu B; Huang Z; Xu P; Zheng H; Yin Y; Xu H; Liu X; Chen L; Lou Y; Zhang X; Xiong F
    Carbohydr Polym; 2014 Oct; 111():928-35. PubMed ID: 25037433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prodrug strategy based on chitosan for efficient intracellular anticancer drug delivery.
    Chen C; Zhou JL; Han X; Song F; Wang XL; Wang YZ
    Nanotechnology; 2014 Jun; 25(25):255101. PubMed ID: 24896540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a photoresponsive chitosan conjugated prodrug nano-carrier for controlled delivery of antitumor drug 5-fluorouracil.
    Horo H; Das S; Mandal B; Kundu LM
    Int J Biol Macromol; 2019 Jan; 121():1070-1076. PubMed ID: 30342947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric anticancer drugs with pH-controlled activation.
    Ulbrich K; Subr V
    Adv Drug Deliv Rev; 2004 Apr; 56(7):1023-50. PubMed ID: 15066758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization, and in vitro efficacy of O-carboxymethyl chitosan conjugate of melphalan.
    Lu B; Huang D; Zheng H; Huang Z; Xu P; Xu H; Yin Y; Liu X; Li D; Zhang X
    Carbohydr Polym; 2013 Oct; 98(1):36-42. PubMed ID: 23987314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel synthesis and in vitro drug release of polymeric prodrug: Chitosan-O-isopropyl-5'-O-d4T monophosphate conjugate.
    Yang L; Zeng R; Li C; Li G; Qiao R; Hu L; Li Z
    Bioorg Med Chem Lett; 2009 May; 19(9):2566-9. PubMed ID: 19328686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrospun antibacterial chitosan-based fibers.
    Ignatova M; Manolova N; Rashkov I
    Macromol Biosci; 2013 Jul; 13(7):860-72. PubMed ID: 23754600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial Prodrugs to Overcome Bacterial Resistance.
    Jubeh B; Breijyeh Z; Karaman R
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32231026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prodrug Approach: A Successful Tool for Improving Drug Solubility.
    Jornada DH; dos Santos Fernandes GF; Chiba DE; de Melo TR; dos Santos JL; Chung MC
    Molecules; 2015 Dec; 21(1):42. PubMed ID: 26729077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and Bioactivity Assessment of Chitosan-1-Acetic Acid-5-Flurouracil Conjugates as Cancer Prodrugs.
    Mohammed MO; Hussain KS; Haj NQ
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29117097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current prodrug design for drug discovery.
    Hsieh PW; Hung CF; Fang JY
    Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
    Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
    J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity.
    Liu Y; Piao H; Gao Y; Xu C; Tian Y; Wang L; Liu J; Tang B; Zou M; Cheng G
    Int J Nanomedicine; 2015; 10():2295-311. PubMed ID: 25848251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical studies of dendrimer prodrugs.
    Kojima C
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1303-15. PubMed ID: 26028253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic combination of antioxidants, silver nanoparticles and chitosan in a nanoparticle based formulation: Characterization and cytotoxic effect on MCF-7 breast cancer cell lines.
    Nayak D; Minz AP; Ashe S; Rauta PR; Kumari M; Chopra P; Nayak B
    J Colloid Interface Sci; 2016 May; 470():142-152. PubMed ID: 26939078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Horseradish peroxidase-encapsulated chitosan nanoparticles for enzyme-prodrug cancer therapy.
    Cao X; Chen C; Yu H; Wang P
    Biotechnol Lett; 2015 Jan; 37(1):81-8. PubMed ID: 25257586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design strategies in the prodrugs of HIV-1 protease inhibitors to improve the pharmaceutical properties.
    Subbaiah MAM; Meanwell NA; Kadow JF
    Eur J Med Chem; 2017 Oct; 139():865-883. PubMed ID: 28865281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic research of peptide spacers controlling drug release from macromolecular prodrug system, carboxymethyldextran polyalcohol-peptide-drug conjugates.
    Shiose Y; Kuga H; Ohki H; Ikeda M; Yamashita F; Hashida M
    Bioconjug Chem; 2009 Jan; 20(1):60-70. PubMed ID: 19090781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.